Integra LifeSciences Holdings Corporation

NasdaqGS:IART 株式レポート

時価総額:US$1.8b

Integra LifeSciences Holdings マネジメント

マネジメント 基準チェック /44

Integra LifeSciences Holdingsの CEO はJan De Witteで、 Dec2021年に任命され、 の在任期間は 2.92年です。 の年間総報酬は$ 6.39Mで、 13.7%給与と86.3%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.031%を直接所有しており、その価値は$ 549.82K 。経営陣と取締役会の平均在任期間はそれぞれ3.6年と11.5年です。

主要情報

Jan De Witte

最高経営責任者

US$6.4m

報酬総額

CEO給与比率13.7%
CEO在任期間2.9yrs
CEOの所有権0.03%
経営陣の平均在職期間3.6yrs
取締役会の平均在任期間11.5yrs

経営陣の近況

Recent updates

There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Nov 05
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise

Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Oct 24
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Sep 08
Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S

Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

Aug 21
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?

At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Jul 01
At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Integra LifeSciences Still Underperforming As Manufacturing Issues Linger

Jun 21

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

May 28
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

Feb 27
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Feb 11
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jan 14
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Dec 31
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Dec 03
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Nov 06
Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Oct 24
Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Sep 22
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Aug 15
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Jul 03
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jun 19
Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

May 05
Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Apr 07
These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

Mar 26
Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Mar 14
At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Feb 27
Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Feb 02
Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Jan 05
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

Dec 21
Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Dec 08
When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

CEO報酬分析

Integra LifeSciences Holdings の収益と比較して、Jan De Witte の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$7m

Jun 30 2024n/an/a

US$24m

Mar 31 2024n/an/a

US$40m

Dec 31 2023US$6mUS$875k

US$68m

Sep 30 2023n/an/a

US$101m

Jun 30 2023n/an/a

US$131m

Mar 31 2023n/an/a

US$172m

Dec 31 2022US$9mUS$850k

US$181m

Sep 30 2022n/an/a

US$173m

Jun 30 2022n/an/a

US$166m

Mar 31 2022n/an/a

US$157m

Dec 31 2021US$899kUS$59k

US$169m

報酬と市場: Janの 総報酬 ($USD 6.39M ) は、 US市場 ($USD 5.43M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Janの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Jan De Witte (60 yo)

2.9yrs

在職期間

US$6,388,756

報酬

Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Stuart Essig
Executive Chairman26.9yrsUS$422.52k2.27%
$ 40.3m
Jan De Witte
President2.9yrsUS$6.39m0.031%
$ 549.8k
Lea Knight
Executive VP & CFO1.4yrsUS$1.67m0.054%
$ 964.6k
Jeffrey Mosebrook
Senior VP of Finance & Principal Accounting Officer7.1yrsUS$1.25m0.047%
$ 830.1k
Eric Schwartz
Executive VP6yrsUS$1.62m0.082%
$ 1.5m
Robert Davis
Executive VP & President of Tissue Technologies11.9yrsUS$1.42m0.084%
$ 1.5m
Michael McBreen
Executive VP & President of Codman Specialty Surgical4.5yrsUS$2.83m0.075%
$ 1.3m
Stephen Leonard
Corporate VP of Global Operations & Supply Chain4.3yrsデータなしデータなし
Laurene Isip
Vice President of Global Corporate Communications & Public Relationsno dataデータなしデータなし
Ruth Fleming
Vice President of Global Marketingno dataデータなしデータなし
Chantal Veillon-Berteloot
Executive VP & Chief Human Resources Officer1.8yrsデータなし0.032%
$ 560.6k
Mark Jesser
Corporate VP & Chief Digital Officer2.8yrsデータなしデータなし

3.6yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: IARTの経営陣は 経験豊富 であると考えられます ( 3.6年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Stuart Essig
Executive Chairman26.9yrsUS$422.52k2.27%
$ 40.3m
Jan De Witte
President2.9yrsUS$6.39m0.031%
$ 549.8k
Raymond Murphy
Independent Director15.6yrsUS$297.54k0.11%
$ 1.9m
Christian Schade
Independent Director18.8yrsUS$293.28k0.082%
$ 1.5m
Barbara Hill
Independent Presiding Director11.5yrsUS$342.54k0.18%
$ 3.1m
Keith N. Bradley
Independent Director32.8yrsUS$306.31k0.091%
$ 1.6m
Jeffrey Graves
Independent Directorless than a yearUS$90.68k0.016%
$ 287.3k
Shaundra Clay
Independent Director3.6yrsUS$260.04k0.028%
$ 504.2k
Renee Lo
Independent Director2.3yrsUS$297.54k0.021%
$ 371.5k

11.5yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: IARTの 取締役会 は経験豊富で 経験豊富 です ( 11.5年の平均在任期間)。